BIOMAT Database Logo BIOMAT Database Logo

Intraplacental choriocarcinoma with fetomaternal hemorrhage: a case study and literature review. 2008

Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya

UI MeSH Term Description Entries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D010922 Placenta Diseases Pathological processes or abnormal functions of the PLACENTA. Placenta Disorders,Placental Diseases,Disease, Placenta,Disease, Placental,Diseases, Placenta,Diseases, Placental,Disorder, Placenta,Disorders, Placenta,Placenta Disease,Placenta Disorder,Placental Disease
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005260 Female Females
D005331 Fetomaternal Transfusion Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed) Hemorrhage, Fetomaternal,Fetomaternal Hemorrhage,Fetomaternal Hemorrhages,Fetomaternal Transfusions,Hemorrhages, Fetomaternal,Transfusion, Fetomaternal,Transfusions, Fetomaternal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Intraplacental choriocarcinoma coexisting with fetomaternal hemorrhage: Case report, chemotherapy management, and literature review.
April 2018, Medicine,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Fetomaternal hemorrhage caused by intraplacental choriocarcinoma: a case report and review of literature in Japan.
January 2006, American journal of perinatology,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
[Fetomaternal hemorrhage caused by intraplacental choriocarcinoma].
April 2010, Journal de gynecologie, obstetrique et biologie de la reproduction,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Massive fetomaternal hemorrhage caused by an intraplacental choriocarcinoma: a case report.
January 2010, Case reports in medicine,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Intraplacental choriocarcinoma with fetomaternal transfusion.
March 2000, Pathology international,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Prenatal findings in a case of massive fetomaternal hemorrhage associated with intraplacental choriocarcinoma.
January 2009, Fetal diagnosis and therapy,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Fetomaternal hemorrhage: a clue to intraplacental choriocarcinoma and neonatal malignancy.
December 2022, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review.
December 2023, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Fetomaternal hemorrhage with intraplacental chorioangioma.
February 2013, The journal of obstetrics and gynaecology research,
Hironori Takahashi, and Hideo Matsuda, and Yoshifumi Mizumoto, and Kenichi Furuya
Biochemical analysis of intraplacental choriocarcinoma and fetomaternal transfusion.
March 2017, The journal of obstetrics and gynaecology research,
Copied contents to your clipboard!